ABSTRACT

Percutaneous repair of mitral regurgitation (MR) with the MitraClip® System (Abbott Vascular, Abbott Park, Illinois, USA) is a novel interventional technique developed as alternative to surgical approaches for the patients considered at high risk for conventional cardiac surgery. It is the most commonly used percutaneous procedure for MR therapy and currently the only transcatheter device which received the CE mark in Europe.